Establishment of Enzyme Immunoassay of Human Thrombomodulin in Plasma and Urine Using Monoclonal Antibodies

Summary

Thrombomodulin, TM, is an endothelial cell membrane protein acting as a cofactor for the activation of plasma protein C. Soluble TM is present in plasma and urine of normal subjects. Enzyme immunoassay, EIA, for human TM was developed using mouse monoclonal antibodies against human placental TM in this paper. We obtained four types of the monoclonal antibodies against human placental TM. EIA sandwich method using three types of the monoclonal antibodies enabled us to measure almost all of 6 and 7 TM subspecies in plasma and urine, respectively, except 1 subspecies, 31 kDa TM. There was no interference from other components of plasma and urine in the assay conditions. Titration curves of purified TM in buffer or in normal plasma were linear within the range from 0.08 to 10 ng/ml. The coefficient of variation at 0.08 ng/ml TM was 4.7%. TM titer with buffer, assayed by this method, was reduced by the addition of thrombin at the final concentration of 20 U/ml, but the titer with plasma was not reduced even at 100 U/ml. These concentrations of thrombin are far larger than those which would be formed in circulation. TM levels in plasma and urine of normal subjects collected in the morning were 35.2 ± 8.32 ng/ml (n = 346) and 111 ± 31.6 ng/ml (n = 33), respectively. TM level in plasma did not differ from the level in serum. Circadian fluctuation of plasma TM was not significant in 10 normal adults, although a tendency of increase in TM excretion to urine was found rather in the day time than the other times. It was concluded that this EIA is reliable for TM assay in human plasma and urine, which will reflect activation or injury of endothelial cells.

• References

• 1 Esmon CT, Owen WG. Identification of an endothelial cell cofactor for thrombin-catalyzed activation of protein C. Proc Natl Acad Sci USA 1981; 78: 2249-2252
• 2 Suzuki K, Stenflo J, Dahlbäck B, Teodorsson G. Inactivation of human coagulation factor V by activated protein C. J Biol Chem 1983; 258: 1914-1920
• 3 Walker FJ, Seston PW, Esmon CT. The inhibition of blood coagulation by activated protein C through the selective inactivation of activated factor V. Biochim Biophys Acta 1979; 571: 333-342
• 4 Ishii H, Majerus PW. Thrombomodulin is present in human plasma and urine. J Clin Invest 1985; 76: 2178-2181
• 5 Salem HH, Maruyama I, Ishii H, Majerus PW. Isolation and characterization of thrombomodulin from human placenta. J Biol Chem 1984; 259: 12246-12251
• 6 Stenflo J. A new vitamin K-dependent protein: purification from bovine plasma and preliminary characterization. J Biol Chem 1976; 251: 355-363
• 7 Lindmark R, Thoren-Tolling K, Sjoquist J. Protein A – an immunoglobulin-binding cell wall protein in Staphylococcus. J Immunol Methods 1983; 62: 1-13
• 8 Kohler G, Milstein C. Continous culture of fused cells secreting antibody of predefined specificity. Nature 1975; 256: 495-497
• 9 Nakane PK. Preparation and standardization of enzyme-labeled conjugates. In: Immunoassays in the Clinical Laboratory Nakamura RM, Dito WR, Tucker ES. (eds) Alan R Liss Inc; New York: 1975. pp 81-87
• 10 Parham P. On the fragmentation of monoclonal IgG₁, IgG₂ and IgG_2b from Balb/c mice. J Immunol 1983; 136: 2895-2902
• 11 Ishikawa E, Hashida S, Kohno T, Kotani T, Ohtaki S. Modification of monoclonal antibodies with enzyme, biotin and fluoioeliromes and their applications. In: Monoclonal Antibodies Production Techniques and Application Schook TB. (ed) Marcel Dekker; New York: 1987. pp 113-137
• 12 Newman PJ, Kahr RA, Hines AJ. Detection and characterization of monoclonal antibodies to platelet membrane proteins. Cell Biol 1981; 90: 249-253
• 13 Laemmli VK. Cleavage of structural protein during the assembly of the lieud of the baeteiiophage T4. Nature 1970; 227: 680-685
• 14 Koide T. Isolation and characterization of antithrombin III from human, porcine and rabbit plasma, and rat serum. J Biochem 1979; 86: 1841-1850
• 15 Tanaka M, Kato K. Determination of antithrombin III by sandwich enzymeimmnnnassay. Thromb Res 1981; 22: 67-74
• 16 Fornasari PM, Gamba G, Dolci D, Gratton T, Ascari F. Circadian rhythms in fibrinolysis. In: Haemostasis and Thrombosis. Proc Serono Symp 15 Serneri N. Prentice CRM; (eds) Academic Press, London: 1979. pp 773-777
• 17 Cepelak V, Barcal R, Cepelakova H, Mayer O. Circadian rhythm of fibrinolysis. In: Progress in Chemical Fibrinolysis and Thrombosis Davidson JF, Rowan R. (eds) Raven Press; New York: 1978. pp 571-578
• 18 Kluft C, Jie AF H, Rijken J, Verheijen JH. Daytime fluctuations in blood of tissue-type plasminogen activator (t-PA) and its fast-acting inhibitor (PAI-1). Thromb Haemostas 1988; 59: 329-332
• 19 Kumada T, Dittman WA, Majerus PW. A role for thrombomodulin in the pathogenesis of thrombin-induced thromboembolism in mice. Blood 1988; 71: 728-733